David Novak analyst STIFEL

Covered Stocks

David Novak

Work

Analyst David Novak works at STIFEL and is focused on the Healthcare sector with 29 price targets and ratings documented since 2018 spanning on 5 stocks. Previously, David Novak worked at RAYMOND JAMES. Analyst's average stock valuation to be materialised ratio is 60.71% with an average time for price targets to be met of 127.25 days.

Most recent stock forecast was given on ZYME, Zymeworks Inc at 10-Dec-2021.

David Novak best performing recommendations are on LPTX.
The best stock recommendation documented was for LPTX at 9/13/2021. The price target of $4 was fulfilled within 17 days with a profit of $2.23 (125.99%) receiving and performance score of 74.11.

Average potential price target upside

CBIO ZYME LPTX TCRT ZIOP
CBIO ZYME LPTX TCRT ZIOP